• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影像学在进展性胶质母细胞瘤管理中的作用:系统评价和循证临床实践指南。

The role of imaging in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.

机构信息

Department of Neurosurgery, Iowa Spine and Brain Institute, Waterloo, IA, USA,

出版信息

J Neurooncol. 2014 Jul;118(3):435-60. doi: 10.1007/s11060-013-1330-0. Epub 2014 Apr 9.

DOI:10.1007/s11060-013-1330-0
PMID:24715656
Abstract

QUESTION

Which imaging techniques most accurately differentiate true tumor progression from pseudo-progression or treatment related changes in patients with previously diagnosed glioblastoma?

TARGET POPULATION

These recommendations apply to adults with previously diagnosed glioblastoma who are suspected of experiencing progression of the neoplastic process.

RECOMMENDATIONS LEVEL II

Magnetic resonance imaging with and without gadolinium enhancement is recommended as the imaging surveillance method to detect the progression of previously diagnosed glioblastoma.

LEVEL II

Magnetic resonance spectroscopy is recommended as a diagnostic method to differentiate true tumor progression from treatment-related imaging changes or pseudo-progression in patients with suspected progressive glioblastoma.

LEVEL III

The routine use of positron emission tomography to identify progression of glioblastoma is not recommended.

LEVEL III

Single-photon emission computed tomography imaging is recommended as a diagnostic method to differentiate true tumor progression from treatment-related imaging changes or pseudo-progression in patients with suspected progressive glioblastoma.

摘要

问题

哪些影像学技术最能准确地区分真性肿瘤进展与复发性胶质母细胞瘤患者中的假性进展或治疗相关变化?

目标人群

这些建议适用于先前诊断为胶质母细胞瘤且疑似肿瘤进展的成人患者。

建议等级 II:建议使用磁共振成像(MRI)联合或不联合钆增强作为影像学监测方法,以检测先前诊断的胶质母细胞瘤的进展。

等级 II:建议磁共振波谱分析作为一种诊断方法,以区分疑似进展性胶质母细胞瘤患者中的真性肿瘤进展与治疗相关的影像学改变或假性进展。

等级 III:不建议常规使用正电子发射断层扫描(PET)来识别胶质母细胞瘤的进展。

等级 III:建议单光子发射计算机断层扫描(SPECT)成像作为一种诊断方法,以区分疑似进展性胶质母细胞瘤患者中的真性肿瘤进展与治疗相关的影像学改变或假性进展。

相似文献

1
The role of imaging in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.影像学在进展性胶质母细胞瘤管理中的作用:系统评价和循证临床实践指南。
J Neurooncol. 2014 Jul;118(3):435-60. doi: 10.1007/s11060-013-1330-0. Epub 2014 Apr 9.
2
Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of imaging in the management of progressive glioblastoma in adults.神经外科学会对成人进行性胶质母细胞瘤管理中影像学作用的系统评价和循证指南更新。
J Neurooncol. 2022 Jun;158(2):139-165. doi: 10.1007/s11060-021-03853-0. Epub 2021 Oct 25.
3
C-methionine in the diagnostics and management of glioblastoma patients with rapid early progression: nonrandomized, open label, prospective clinical trial (GlioMET).C-蛋氨酸在快速早期进展型胶质母细胞瘤患者诊断和治疗中的应用:非随机、开放标签、前瞻性临床试验(Gliomet)。
BMC Cancer. 2024 Jun 15;24(1):736. doi: 10.1186/s12885-024-12469-2.
4
The role of neuropathology in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.神经病理学在进展性胶质母细胞瘤管理中的作用:系统评价和基于证据的临床实践指南。
J Neurooncol. 2014 Jul;118(3):461-78. doi: 10.1007/s11060-013-1331-z. Epub 2014 Apr 15.
5
Congress of neurological surgeons systematic review and evidence-based guidelines for the role of imaging in newly diagnosed WHO grade II diffuse glioma in adults: update.神经外科医生大会关于影像学在成人新诊断的世界卫生组织II级弥漫性胶质瘤中的作用的系统评价和循证指南:更新版
J Neurooncol. 2025 May 8. doi: 10.1007/s11060-025-05043-8.
6
Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of chemotherapy in newly diagnosed WHO Grade II diffuse glioma in adults: update.神经外科医生大会关于化疗在成人新诊断的世界卫生组织二级弥漫性胶质瘤中作用的系统评价和循证指南:更新版
J Neurooncol. 2025 Jan;171(2):279-298. doi: 10.1007/s11060-024-04861-6. Epub 2024 Nov 20.
7
The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)在结直肠癌术前分期中的价值:系统评价和经济评估。
Health Technol Assess. 2011 Sep;15(35):1-192, iii-iv. doi: 10.3310/hta15350.
8
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
9
[F]FET PET-Guided management of pseudoprogression in glioblastoma (FET POPPING): the study protocol for a diagnostic randomized clinical trial.[F]氟代乙基酪氨酸正电子发射断层扫描引导下胶质母细胞瘤假性进展的管理(FET POPPING):一项诊断性随机临床试验的研究方案
Trials. 2025 Jun 17;26(1):208. doi: 10.1186/s13063-025-08921-8.
10
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.用于诊断神经母细胞瘤的123I-间碘苄胍闪烁扫描术和18F-氟代脱氧葡萄糖正电子发射断层显像
Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD009263. doi: 10.1002/14651858.CD009263.pub2.

引用本文的文献

1
Diagnostic Approaches to Adult-Type Diffuse Glial Tumors: Comparative Literature and Clinical Practice Study.成人弥漫性神经胶质瘤的诊断方法:文献比较与临床实践研究。
Curr Oncol. 2023 Aug 24;30(9):7818-7835. doi: 10.3390/curroncol30090568.
2
Diffusion imaging could aid to differentiate between glioma progression and treatment-related abnormalities: a meta-analysis.扩散成像有助于鉴别胶质瘤进展与治疗相关异常:一项荟萃分析。
Insights Imaging. 2022 Oct 4;13(1):158. doi: 10.1186/s13244-022-01295-4.
3
Pseudoprogression prediction in high grade primary CNS tumors by use of radiomics.

本文引用的文献

1
Comparison of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET in differentiating radiation necrosis from recurrent glioma.18F-氟脱氧葡萄糖和 18F-氟胸腺嘧啶 PET 鉴别放射性坏死与复发性脑胶质瘤的比较。
Clin Nucl Med. 2012 Sep;37(9):854-61. doi: 10.1097/RLU.0b013e318262c76a.
2
Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival.重新评估肿瘤进展的影像学定义:灌注 MRI 定量评估复发性脑胶质瘤肿瘤部分、假性进展和放射性坏死,以预测患者的生存情况。
Neuro Oncol. 2012 Jul;14(7):919-30. doi: 10.1093/neuonc/nos112. Epub 2012 May 3.
3
基于影像组学预测高级别原发性中枢神经系统肿瘤的假性进展
Sci Rep. 2022 Apr 8;12(1):5915. doi: 10.1038/s41598-022-09945-9.
4
High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 1: Perfusion and Diffusion Techniques.高级别胶质瘤治疗反应监测生物标志物:关于支持在临床中使用先进MRI技术的证据以及最新的从 bench 到 bedside 进展的立场声明。第1部分:灌注和扩散技术。
Front Oncol. 2022 Mar 3;12:810263. doi: 10.3389/fonc.2022.810263. eCollection 2022.
5
Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of targeted therapies and immunotherapies in the management of progressive glioblastoma.神经外科学会对靶向治疗和免疫疗法在进展性胶质母细胞瘤治疗中的作用的系统评价和循证指南更新。
J Neurooncol. 2022 Jun;158(2):265-321. doi: 10.1007/s11060-021-03876-7. Epub 2021 Oct 25.
6
Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of imaging in the management of progressive glioblastoma in adults.神经外科学会对成人进行性胶质母细胞瘤管理中影像学作用的系统评价和循证指南更新。
J Neurooncol. 2022 Jun;158(2):139-165. doi: 10.1007/s11060-021-03853-0. Epub 2021 Oct 25.
7
Magnetic Particle Imaging: Current and Future Applications, Magnetic Nanoparticle Synthesis Methods and Safety Measures.磁粒子成像:当前和未来的应用,磁性纳米粒子的合成方法和安全措施。
Int J Mol Sci. 2021 Jul 17;22(14):7651. doi: 10.3390/ijms22147651.
8
Reduced Serum sRANKL and sTREM2 Levels in High-Grade Gliomas: Association with Prognosis.高级别胶质瘤患者血清sRANKL和sTREM2水平降低:与预后的关系
Noro Psikiyatr Ars. 2021 Jun 3;58(2):133-136. doi: 10.29399/npa.27536. eCollection 2021 Jun.
9
Analyzing magnetic resonance imaging data from glioma patients using deep learning.利用深度学习分析脑胶质瘤患者的磁共振成像数据。
Comput Med Imaging Graph. 2021 Mar;88:101828. doi: 10.1016/j.compmedimag.2020.101828. Epub 2020 Dec 2.
10
From cells to tissue: How cell scale heterogeneity impacts glioblastoma growth and treatment response.从细胞到组织:细胞尺度异质性如何影响胶质母细胞瘤的生长和治疗反应。
PLoS Comput Biol. 2020 Feb 26;16(2):e1007672. doi: 10.1371/journal.pcbi.1007672. eCollection 2020 Feb.
Comparison of F-18 FDG and C-11 methionine PET/CT for the evaluation of recurrent primary brain tumors.
F-18 FDG 与 C-11 蛋氨酸 PET/CT 对比评估原发性脑肿瘤复发。
Clin Nucl Med. 2012 Feb;37(2):158-63. doi: 10.1097/RLU.0b013e318238f51a.
4
Improved survival time trends for glioblastoma using the SEER 17 population-based registries.使用 SEER 17 基于人群的登记处改善胶质母细胞瘤的生存时间趋势。
J Neurooncol. 2012 Mar;107(1):207-12. doi: 10.1007/s11060-011-0738-7. Epub 2011 Oct 9.
5
Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of Surveillance, Epidemiology, and End Results registries.成人多形性胶质母细胞瘤在替莫唑胺时代的生存:监测、流行病学和最终结果登记处的基于人群的分析。
Cancer. 2012 Apr 15;118(8):2163-72. doi: 10.1002/cncr.26494. Epub 2011 Aug 31.
6
Advances in PET imaging of brain tumors: a referring physician's perspective.脑肿瘤正电子发射断层扫描成像的进展:临床医生的视角。
Curr Opin Oncol. 2011 Nov;23(6):617-23. doi: 10.1097/CCO.0b013e32834aa752.
7
The concepts, diagnosis and management of early imaging changes after therapy for glioblastomas.治疗胶质母细胞瘤后早期影像学改变的概念、诊断和处理。
Clin Oncol (R Coll Radiol). 2012 Apr;24(3):216-27. doi: 10.1016/j.clon.2011.06.004. Epub 2011 Jul 23.
8
MRI and thallium-201 SPECT in the prediction of survival in glioma.磁共振成像和铊-201 单光子发射计算机断层扫描在预测脑胶质瘤患者生存中的作用。
Neuroradiology. 2012 Jun;54(6):539-46. doi: 10.1007/s00234-011-0908-5. Epub 2011 Jul 14.
9
Canadian recommendations for the treatment of recurrent or progressive glioblastoma multiforme.加拿大复发性或进行性多形性胶质母细胞瘤治疗推荐。
Curr Oncol. 2011 Jun;18(3):e126-36. doi: 10.3747/co.v18i3.755.
10
Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment.前瞻性分析参数反应图衍生的 MRI 生物标志物:识别标准影像学评估无法预测的早期且独特的脑胶质瘤反应模式。
Clin Cancer Res. 2011 Jul 15;17(14):4751-60. doi: 10.1158/1078-0432.CCR-10-2098. Epub 2011 Apr 28.